Product Search
We provide safer and differentiated healthcare products to customers
by combining medical technologies.
PRODUCT
Ahngook Cilostazol tab.
Print
product information
Ahngook Cilostazol tab.
| Classification | Ethical the Counter(ETC) |
|---|---|
| Major Ingredients | Cilostazol |
| Efficacy/Effectiveness | Treatment of intermittent claudication |
| Appearance |
product information
Details
1) Composition
Cilostazol------------50mg
2) Dosage and Administration
100mg twice a day
3) Indications
Cilostazol is approved for the treatment of intermittent claudication. The typical dose is 100 mg twice a day. The effects may take as much as 3 months to be evident.
4) Mechanism of action
Cilostazol is a selective cAMP phosphodiesterase inhibitor. It inhibits platelet aggregation and is a direct arterial vasodilator. Its main effects are dilation of the arteries supplying blood to the legs and decreasing platelet coagulation
5) Stroage
tight container, at room temperature
6) Expiry date
36 months from manufactured date
Cilostazol------------50mg
2) Dosage and Administration
100mg twice a day
3) Indications
Cilostazol is approved for the treatment of intermittent claudication. The typical dose is 100 mg twice a day. The effects may take as much as 3 months to be evident.
4) Mechanism of action
Cilostazol is a selective cAMP phosphodiesterase inhibitor. It inhibits platelet aggregation and is a direct arterial vasodilator. Its main effects are dilation of the arteries supplying blood to the legs and decreasing platelet coagulation
5) Stroage
tight container, at room temperature
6) Expiry date
36 months from manufactured date